Genmab to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference in London

Company Overview - Genmab A/S is an international biotechnology company focused on improving the lives of patients through innovative antibody therapeutics [2][3] - Established in 1999 and headquartered in Copenhagen, Denmark, Genmab has a global presence across North America, Europe, and Asia Pacific [3] Upcoming Events - Genmab's CEO Jan Van de Winkel and CFO Anthony Pagano will participate in a fireside chat at the Jefferies Global Healthcare Conference in London on November 19, 2025, at 12:00 PM GMT [1] - A webcast of the event will be available on Genmab's website [1] Strategic Vision - By 2030, Genmab aims to transform the lives of individuals with cancer and other serious diseases through its innovative antibody medicines, referred to as "knock-your-socks-off" (KYSO) therapies [2]